We recently reported that Michael Granston, Director of the Civil Fraud Section of the Department of Justice (DOJ), made comments during a November 2017 healthcare compliance conference suggesting that in cases where the DOJ has determined allegations in a qui tam (or "whistleblower") lawsuit lack merit, the government may more aggressively exercise its statutory authority - rarely used in the past - to dismiss such cases.

The battle over 340B continues as hospitals serving some of the nation's most vulnerable patients worry what will happen if $1.6 billion in cuts go through.

Not every major action takes an act of legislation.

The Department of Justice (DOJ) recently made a surprising announcement that it may begin seeking dismissal of meritless qui tam cases brought under the False Claims Act.

Last year drew to a close with promises for the swift repeal and replacement of the Affordable Care Act after the inauguration of Donald Trump.

During last year's Alabama legislative session, Senator Trip Pittman introduced a proposal to rein in the costs of malpractice suits. Senate Bill 413 would have replaced the trial-based system with a no-blame, administrative one.

As providers who are currently undergoing a Medicare claims appeal know, there is a lengthy delay to having an appeal actually heard by an Administrative Law Judge (ALJ). Some estimates indicate that it will currently take over 10 years to have an appeal heard.

The Department of Health and Human Services Office of the Inspector (OIG ) recently issued an advisory opinion that determined that a vaccine storage and dispensing system with a per-dispense fee did not violate the Anti-Kickback Statute.

Unfortunately for most healthcare providers, the Office of Inspector General of the US Department of Health & Human Services (OIG) continues to demand and receive large settlements under the Physician Self-Referral Law found at 42 US Code Section 1395nnn (Stark Act).